65 records – page 1 of 4.

Select Title Policy Type Year
EspAddText
EspRemoveText
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology Parliamentary submission 2012
EspAddText
EspRemoveText
Putting Patients First : Comments on Bill C 6 (Personal Information Protection and Electronic Documents Act) : Submission to the Senate Standing Committee on Social Affairs, Science and Technology Parliamentary submission 2019
EspAddText
EspRemoveText
Listening to our Patient's Concerns : Comments on Bill C 54 (Personal Information Protection and Electronic Document Act) : Submission to the House of Commons Standing Committee on Industry Parliamentary submission 2019
EspAddText
EspRemoveText
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages Parliamentary submission 2012
EspAddText
EspRemoveText
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval Parliamentary submission 2012
EspAddText
EspRemoveText
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals Parliamentary submission 2012
EspAddText
EspRemoveText
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal Parliamentary submission 2013
EspAddText
EspRemoveText
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health Parliamentary submission 2013
EspAddText
EspRemoveText
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations Response to consultation 2014
EspAddText
EspRemoveText
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety Parliamentary submission 2014
EspAddText
EspRemoveText
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase Parliamentary submission 2014
EspAddText
EspRemoveText
The Health risks and harms associated with the use of marijuana Parliamentary submission 2014
EspAddText
EspRemoveText
Amendments to PIPEDA, Bill S-4 Parliamentary submission 2014
EspAddText
EspRemoveText
Bill C-17 An Act to amend the Food and Drugs Act Parliamentary submission 2014
EspAddText
EspRemoveText
Proposed amendments to the marihuana for medical purposes regulations Response to consultation 2014
EspAddText
EspRemoveText
Tamper Resistance under the Controlled Drugs and Substances Act Response to consultation 2014
EspAddText
EspRemoveText
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act) Parliamentary submission 2014
EspAddText
EspRemoveText
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act) Parliamentary submission 2015
EspAddText
EspRemoveText
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) Response to consultation 2015
EspAddText
EspRemoveText
CMA’s formal submission to the Federal External Panel on assisted dying Parliamentary submission 2019

65 records – page 1 of 4.